IperionX Limited Sponsored ADR (NASDAQ:IPX) Receives Average Rating of “Moderate Buy” from Analysts

IperionX Limited Sponsored ADR (NASDAQ:IPX) has been assigned an average rating of “Moderate Buy” from the six ratings firms that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating and five have given a buy rating to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $60.3333.

IPX has been the subject of several recent analyst reports. Roth Mkm reaffirmed a “buy” rating on shares of IperionX in a report on Monday, June 8th. BTIG Research raised their price objective on shares of IperionX from $40.00 to $55.00 and gave the stock a “buy” rating in a report on Friday, June 5th. Alliance Global Partners reaffirmed a “buy” rating on shares of IperionX in a report on Tuesday, April 28th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of IperionX in a report on Tuesday, April 21st. Finally, B. Riley Financial dropped their price objective on shares of IperionX from $58.00 to $52.00 and set a “buy” rating for the company in a report on Friday, March 13th.

IperionX Stock Performance

Shares of IPX opened at $36.05 on Wednesday. The company has a debt-to-equity ratio of 0.03, a quick ratio of 4.00 and a current ratio of 4.03. IperionX has a 12 month low of $21.66 and a 12 month high of $61.45. The company has a 50-day moving average price of $35.16 and a two-hundred day moving average price of $38.21.

IperionX (NASDAQ:IPX) last announced its quarterly earnings results on Saturday, January 31st. The company reported ($0.50) EPS for the quarter. On average, research analysts predict that IperionX will post -0.18 EPS for the current year.

Insider Activity at IperionX

In other news, CEO Anastasios Arima acquired 110,000 shares of the company’s stock in a transaction dated Tuesday, April 28th. The stock was bought at an average price of $4.49 per share, with a total value of $493,900.00. Following the completion of the acquisition, the chief executive officer owned 12,316,782 shares in the company, valued at approximately $55,302,351.18. This represents a 0.90% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Chairman Todd Hannigan acquired 260,000 shares of the company’s stock in a transaction dated Wednesday, April 29th. The shares were purchased at an average cost of $4.20 per share, with a total value of $1,092,000.00. Following the acquisition, the chairman owned 26,108,334 shares of the company’s stock, valued at approximately $109,655,002.80. This represents a 1.01% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last ninety days, insiders have bought 590,000 shares of company stock valued at $2,571,500.

Institutional Trading of IperionX

Hedge funds and other institutional investors have recently modified their holdings of the stock. Jones Financial Companies Lllp acquired a new stake in shares of IperionX in the third quarter valued at approximately $36,000. JPMorgan Chase & Co. acquired a new stake in shares of IperionX in the second quarter valued at approximately $66,000. State of Tennessee Department of Treasury acquired a new stake in shares of IperionX in the fourth quarter valued at approximately $119,000. DV Equities LLC acquired a new stake in shares of IperionX in the fourth quarter valued at approximately $178,000. Finally, Man Group plc acquired a new stake in shares of IperionX in the fourth quarter valued at approximately $257,000. Institutional investors and hedge funds own 2.76% of the company’s stock.

IperionX Company Profile

IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high‐purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.

At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.